Medical Devices Global

Global Insulin Pens Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Global Insulin Pens Market Industry Trends and Forecast to 2034: Segmented by (Type, Needle, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Global · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $3.13 Bn Placeholder estimate
Estimate 2025 $3.38 Bn Placeholder estimate
Projected 2034 $6.76 Bn 99.9% Adds $3.38 Bn over 9 forecast years
CAGR 2025–2034 8.0% Faster than 41% of 193 Medical Devices markets here
Key players 6 +1
  • Worldwide, the largest is US at $1.52 Bn.
  • Fastest growing: India at 11.3% a year.

Market size projection

Global

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$3.38 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Insulin Pens Market market size by year, Global
YearMarket sizeChange that yearSince 2025
2024 (estimate) $3.13 Bn — —
2025 (base) $3.38 Bn +$250.6 Mn —
2026 (forecast) $3.65 Bn +$270.6 Mn +8%
2027 (forecast) $3.95 Bn +$292.3 Mn +16.6%
2028 (forecast) $4.26 Bn +$315.6 Mn +26%
2029 (forecast) $4.60 Bn +$340.9 Mn +36%
2030 (forecast) $4.97 Bn +$368.2 Mn +46.9%
2031 (forecast) $5.37 Bn +$397.6 Mn +58.7%
2032 (forecast) $5.80 Bn +$429.4 Mn +71.4%
2033 (forecast) $6.26 Bn +$463.8 Mn +85.1%
2034 (forecast) $6.76 Bn +$500.9 Mn +99.9%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Global Insulin Pens Market Analysis at a glance
Market size, 2025$3.38 Bn placeholder estimate
Forecast, 2034$6.76 Bn placeholder estimate
Growth (CAGR), 2025–20348.0% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType and needle (see all)
Key playersNovo Nordisk A/S, Eli Lilly and Company, Sanofi, Ypsomed, Owen Mumford and 1 more (see all)
Regulator worldwideIMDRFSource: International Medical Device Regulators Forum. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Global Insulin Pens Market Analysis Executive Summary

Insulin pens are handheld injectors that give set doses of insulin, as a simpler option than vials and syringes.

Key segments of the insulin pens market include type (Prefilled Pens, Reusable Pens and Connected Pens) and needle (Standard Needles and Safety Needles).

Bar chart: Global Insulin Pens market size, 2024–2034, placeholder estimates. $3.13 Bn in 2024, $3.38 Bn in 2025 and $6.76 Bn in 2034, 8.0% CAGR.
Global Insulin Pens market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Global Insulin Pens Market Dynamics

Market Growth Drivers

Rising numbers of people with diabetes, a shift to tools that track and deliver treatment automatically, and more insurance cover are driving the insulin pens market.

Opportunity

Connected devices, lower-priced sensors and new insulins and pills give the insulin pens market room to grow.

Market Restraints

High costs for people without cover, price competition and uneven access to care in low-income countries hold back the insulin pens market.

Competitive Landscape for Insulin Pens Market in Global

The insulin pens market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Insulin Pens Market in Global

Insulin Pens worldwide: rules and payment

There is no single global regulator; the International Medical Device Regulators Forum (IMDRF) helps national regulators align their device rules.⁠[1] WHO reports that 4.5 billion people were not fully covered by essential health services in 2021.⁠[2]

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how insulin pens products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Global.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Insulin Pens right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 21 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Insulin Pens in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Insulin Pens market worldwide?
Placeholder estimate: about $3.38 Bn in 2025, rising to about $6.76 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Insulin Pens market worldwide growing?
Placeholder estimate: about 8.0% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Insulin Pens market report cover?
The report splits the market by type (Prefilled Pens, Reusable Pens, Connected Pens) and needle (Standard Needles, Safety Needles).
Who are the key players in the Insulin Pens market?
Key players include Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Ypsomed, Owen Mumford and BD (Becton, Dickinson).
What is driving the Insulin Pens market?
Rising numbers of people with diabetes, a shift to tools that track and deliver treatment automatically, and more insurance cover are driving the insulin pens market.
Who regulates Insulin Pens worldwide?
There is no single global regulator; the International Medical Device Regulators Forum (IMDRF) helps national regulators align their device rules. Source: International Medical Device Regulators Forum. Checked 14 Nov 2026.
How is healthcare paid for worldwide?
WHO reports that 4.5 billion people were not fully covered by essential health services in 2021. Source: World Health Organization, universal health coverage. Checked 14 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Global

See all

Related on diabetes

See the topic